Literature DB >> 16339181

Arg16Gly polymorphism of the beta2-adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans.

Eric M Snyder1, Kenneth C Beck, Niki M Dietz, John H Eisenach, Michael J Joyner, Stephen T Turner, Bruce D Johnson.   

Abstract

In humans, subjects homozygous for arginine (ArgArg) at codon 16 of the beta2-adrenergic receptor (beta2AR) have been shown to have greater agonist-mediated desensitization than subjects homozygous for glycine (GlyGly). We sought to determine if this substitution differentially influenced cardiovascular function during short duration (9 min) low and high intensity exercise (40 and 75% of peak work). Healthy Caucasian ArgArg (n = 16), GlyGly (n = 31) and ArgGly (n = 17) subjects matched for age, sex and peak oxygen uptake were studied. There were no differences in adrenaline (ADR) at rest or with heavy exercise, but the ArgArg group had lower ADR with light exercise (P = 0.04). Resting heart rate (HR) was higher in ArgArg (P < 0.01), while cardiac output (Q), stroke volume (SV), and mean arterial pressure (MAP) were lower than the other groups (HR = 86+/-2, 78+/-2, 80+/-1 beats min(-1); Q = 5.7+/-0.81, 6.1+/-0.18, 6.7+/-0.22 l min(-1); SV = 68+/-3, 82+/-3, 89+/-4 ml beat(-1); MAP = 92+/-1, 103+/-2, 98+/-1 mmHg-- for ArgArg, ArgGly and GlyGly, respectively, means +/-s.e.m., P < 0.01), however, no differences were observed in systemic vascular resistance (SVR). With low intensity exercise and high intensity exercise the ArgArg group continued to have a lower , SV and MAP compared to the other groups (P < 0.05), with no differences observed in SVR. During recovery, the ArgArg subjects continued to have a lower MAP but there were no differences in HR, , or SVR. These data suggest that subjects homozygous for Arg at codon 16 of the beta2AR have reduced and MAP at rest that persist during exercise with no evidence for differential changes over the course of exercise despite large changes in catecholamines. This may suggest possible genotype-related differences in baseline receptor function or density which causes phenotypic differences at rest that are sustained during short-term exercise.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339181      PMCID: PMC1805638          DOI: 10.1113/jphysiol.2005.098558

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  36 in total

1.  Cardiac output during exercise by the open circuit acetylene washin method: comparison with direct Fick.

Authors:  B D Johnson; K C Beck; D N Proctor; J Miller; N M Dietz; M J Joyner
Journal:  J Appl Physiol (1985)       Date:  2000-05

2.  Beta-adrenergic and muscarinic cholinergic receptor densities in the human sinoatrial node: identification of a high beta 2-adrenergic receptor density.

Authors:  M D Rodefeld; S L Beau; R B Schuessler; J P Boineau; J E Saffitz
Journal:  J Cardiovasc Electrophysiol       Date:  1996-11

3.  Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study.

Authors:  B Timmermann; R Mo; F C Luft; E Gerdts; A Busjahn; P Omvik; G H Li; H Schuster; T F Wienker; M R Hoehe; P Lund-Johansen
Journal:  Kidney Int       Date:  1998-06       Impact factor: 10.612

4.  Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans.

Authors:  H G Xie; C M Stein; R B Kim; J V Gainer; G Sofowora; V Dishy; N J Brown; R E Goree; J L Haines; A J Wood
Journal:  Clin Pharmacol Ther       Date:  2000-06       Impact factor: 6.875

5.  Targeted disruption of the beta2 adrenergic receptor gene.

Authors:  A J Chruscinski; D K Rohrer; E Schauble; K H Desai; D Bernstein; B K Kobilka
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

6.  Blood pressure variation in healthy humans: a possible interaction with beta-2 adrenergic receptor genotype and renal epithelial sodium channels.

Authors:  Eric M Snyder; Michael J Joyner; Stephen T Turner; Bruce D Johnson
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

Review 7.  Implications of genetic variability of human beta 2-adrenergic receptor structure.

Authors:  S A Green; J Turki; I P Hall; S B Liggett
Journal:  Pulm Pharmacol       Date:  1995-02

8.  Functional analysis of myocardial performance in murine hearts overexpressing the human beta 2-adrenergic receptor.

Authors:  H B Bittner; E P Chen; C A Milano; R J Lefkowitz; P Van Trigt
Journal:  J Mol Cell Cardiol       Date:  1997-03       Impact factor: 5.000

9.  Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension.

Authors:  M S Bray; J Krushkal; L Li; R Ferrell; S Kardia; C F Sing; S T Turner; E Boerwinkle
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

10.  Enhanced vasorelaxation by overexpression of beta 2-adrenergic receptors in large arteries.

Authors:  M A Gaballa; K Peppel; R J Lefkowitz; M Aguirre; P C Dolber; G D Pennock; W J Koch; S Goldman
Journal:  J Mol Cell Cardiol       Date:  1998-05       Impact factor: 5.000

View more
  29 in total

1.  The Arg16Gly polymorphism of the beta2-adrenergic receptor and the natriuretic response to rapid saline infusion in humans.

Authors:  Eric M Snyder; Stephen T Turner; Michael J Joyner; John H Eisenach; Bruce D Johnson
Journal:  J Physiol       Date:  2006-05-25       Impact factor: 5.182

Review 2.  Genetics of beta2-adrenergic receptors and the cardiopulmonary response to exercise.

Authors:  Eric M Snyder; Bruce D Johnson; Michael J Joyner
Journal:  Exerc Sport Sci Rev       Date:  2008-04       Impact factor: 6.230

Review 3.  Giant sucking sound: can physiology fill the intellectual void left by the reductionists?

Authors:  Michael J Joyner
Journal:  J Appl Physiol (1985)       Date:  2011-06-02

4.  Interactions between beta-2 adrenoceptor gene variation, cardiovascular control and dietary sodium in healthy young adults.

Authors:  John H Eisenach; Darrell R Schroeder; Emily S Pavey; Alan R Penheiter; Jean N Knutson; Stephen T Turner; Michael J Joyner
Journal:  J Physiol       Date:  2014-09-25       Impact factor: 5.182

5.  The effect of maternal and fetal β2-adrenoceptor and nitric oxide synthase genotype on vasopressor requirement and fetal acid-base status during spinal anesthesia for cesarean delivery.

Authors:  Ruth Landau; Shih-Kai Liu; Jean-Louis Blouin; Richard M Smiley; Warwick D Ngan Kee
Journal:  Anesth Analg       Date:  2011-06       Impact factor: 5.108

Review 6.  {beta}-Adrenoceptor gene variation and intermediate physiological traits: prediction of distant phenotype.

Authors:  John H Eisenach; Erica D Wittwer
Journal:  Exp Physiol       Date:  2010-04-09       Impact factor: 2.969

7.  Arg16Gly and Gln27Glu β2 adrenergic polymorphisms influence cardiac autonomic modulation and baroreflex sensitivity in healthy young Brazilians.

Authors:  Magda M Atala; Alessandra Goulart; Grazia M Guerra; Cristiano Mostarda; Bruno Rodrigues; Priscila R Mello; Dulce E Casarine; Maria-Claudia Irigoyen; Alexandre C Pereira; Fernanda M Consolim-Colombo
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

8.  β-1 and β-2 adrenergic receptor polymorphism and association with cardiovascular response to orthostatic screening.

Authors:  E D Wittwer; Z Liu; N D Warner; D R Schroeder; A M Nadeau; A R Allen; C J Murillo; R L Elvebak; B M Aakre; J H Eisenach
Journal:  Auton Neurosci       Date:  2011-07-31       Impact factor: 3.145

9.  Beta-2 Adrenergic Receptor Genotype Influences Power Output in Healthy Subjects.

Authors:  Eli F Kelley; Bruce D Johnson; Eric M Snyder
Journal:  J Strength Cond Res       Date:  2017-08       Impact factor: 3.775

Review 10.  Genetics and pharmacogenetics in heart failure.

Authors:  Eric M Snyder; Thomas P Olson; Bruce D Johnson
Journal:  Curr Heart Fail Rep       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.